Wellomics

Wellomics is a private U.S. health and wellness company focused on science-based product innovation for the nutraceutical, beverage, functional food, and dietary supplement markets. Rather than operating as a drug-development biotech with a disclosed therapeutic pipeline, the company appears to function primarily as a business-to-business formulation, testing, and product-development partner for consumer health brands. Its capabilities center on combining systems biology, omics, formulation science, and bioavailability-focused delivery technologies to create differentiated natural health products. Publicly available materials describe proprietary formulation approaches and a targeted delivery platform called VegaGel intended to improve absorption of natural ingredients. The company is led by founder and CEO Mark Neveu and has been described as active, private, and headquartered in Massachusetts, with additional references to Maine.